Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
Abstract Intrahepatic cholangiocarcinoma (ICC) is a highly malignant liver tumor associated with a dismal prognosis, largely due to chemotherapy resistance. However, the mechanisms underlying gemcitabine (GEM) resistance in ICC remain poorly understood. In this study, we established three GEM-resist...
Saved in:
Main Authors: | Jiandong Li, Yanxin Hu, Jiayao Zhang, Weiguang Zhang, Jianhua Yu, Baochun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-89423-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report
by: Shuangying Zhao, et al.
Published: (2025-01-01) -
Radiomics and radiogenomics in intrahepatic cholangiocarcinoma
by: A. D. Smirnova, et al.
Published: (2024-03-01) -
Design of studies on neoadjuvant therapy for intrahepatic cholangiocarcinoma
by: Yuan Cheng, et al.
Published: (2025-01-01) -
Preoperative chemotherapy usage experience for intrahepatic cholangiocarcinoma
by: A. N. Polyakov, et al.
Published: (2023-03-01) -
The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review
by: Brian H Dingle, et al.
Published: (2005-01-01)